B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PSMB7

MOLECULAR TARGET

proteasome 20S subunit beta 7

UniProt: Q99436NCBI Gene: 56953 compounds

PSMB7 (proteasome 20S subunit beta 7) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PSMB7

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1carfilzomib3.6939
2Bortezomib2.7114
3Reserpine1.614

About PSMB7 as a Drug Target

PSMB7 (proteasome 20S subunit beta 7) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented PSMB7 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PSMB7 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.